| Tipoffs on New England Newsletter for Monday November 18, 2024 ( 2 items ) |
|
Cleveland Clinic-Led Trial Finds Heart Implant May Be Effective Alternative to Blood Thinners for Those With Atrial Fibrillation
CLEVELAND, Ohio, Nov. 18 (TNSres) -- The Cleveland Clinic issued the following news release:
* * *
OPTION Trial presented at the American Heart Association's Scientific Sessions 2024
* * *
A new Cleveland Clinic-led trial found that a minimally-invasive procedure - left atrial appendage closure - resulted in significantly less bleeding in patients undergoing a catheter ablation to treat atrial fibrillation, compared to blood thinners, while preserving low rates of stroke, blood clots and dea
more
Spironolactone, a blood pressure medication, may help reduce risk of new heart failure
DALLAS, Texas, Nov. 17 [Category: Health Care] -- The American Heart Association issued the following news release:
Research Highlights:
The CLEAR SYNERGY trial found that spironolactone may reduce the risk of new or worsening heart failure; however, it did not significantly impact the rate of death, new heart attack or stroke.
More research is needed to further explore the potential for spironolactone, a blood pressure medication, to prevent heart failure and its long-term impact on an indiv
more
|
Sign up to Receive this newsletter every day via email.